Docetaxel (X-GEN Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Docetaxel drug offered from X-GEN Pharmaceuticals, Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | X-GEN Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | docetaxel |
SUBSTANCE NAME: | DOCETAXEL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-04-17 |
END MARKETING DATE: | 0000-00-00 |
Docetaxel HUMAN PRESCRIPTION DRUG Details:
Item Description | Docetaxel from X-GEN Pharmaceuticals, Inc. |
LABELER NAME: | X-GEN Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/mL) |
START MARKETING DATE: | 2017-04-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 39822-2120_9c81403e-61cf-4381-9bba-db04f665c47d |
PRODUCT NDC: | 39822-2120 |
APPLICATION NUMBER: | ANDA206177 |
Other DOCETAXEL Pharmaceutical Manufacturers / Labelers: